Watchlist Price Alert

Akebia Therapeutics Inc. (AKBA)

NASDAQ: AKBA · Real-Time Price · USD

3.44

0.19 (5.85%)

At close: Jun 03, 2025, 3:59 PM

3.42

-0.44%

Pre-market: Jun 04, 2025, 05:50 AM EDT

Akebia Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	160.18M	194.62M	292.6M	213.58M	295.31M	335M	207.74M	177.98M	1.53M
Cost of Revenue	63.18M	74.15M	84.8M	153.39M	295.91M	145.34M	7.68M	617K	115.78M
Gross Profit	97M	120.47M	207.81M	60.18M	-601K	189.66M	200.06M	177.37M	-114.25M
Operating Income	-50.47M	-46.26M	-63.18M	-265.32M	-376.44M	-286.29M	-178.14M	-79.92M	-136.46M
Interest Income	n/a	n/a	15.69M	19.95M	8.92M	2.19M	6.15M	2.8M	901K
Pretax Income	-69.41M	-51.92M	-92.56M	-282.84M	-383.46M	-286.29M	-171.9M	-76.91M	-135.75M
Net Income	-69.41M	-51.92M	-106.01M	-244.87M	-349.87M	-279.66M	-171.9M	-76.91M	-135.75M
Selling & General & Admin	106.55M	100.23M	141.87M	174.16M	153.95M	149.46M	87.06M	27.01M	22.21M
Research & Development	37.65M	63.08M	129.11M	147.85M	218.49M	322.97M	291.07M	230.89M	115.78M
Other Expenses	3.28M	3.42M	-12.54M	3.49M	3.41M	3.53M	6.24M	204K	-188K
Operating Expenses	147.47M	166.73M	270.99M	325.5M	375.84M	475.95M	378.2M	257.9M	138M
Interest Expense	18.18M	6.03M	15.69M	19.94M	8.87M	1.4M	6.15M	n/a	n/a
Selling & Marketing Expenses	n/a	100.23M	-3.17M	174.16M	153.95M	149.46M	87.06M	n/a	n/a
Cost & Expenses	171.33M	240.88M	355.78M	478.9M	671.75M	621.29M	385.88M	257.9M	138M
Income Tax Expense	n/a	n/a	13.45M	-37.97M	-33.59M	-6.63M	-28.34M	-2.8M	-901K
Shares Outstanding (Basic)	210.95M	187.47M	182.78M	165.95M	138.46M	118.4M	116.89M	43.5M	37.72M
Shares Outstanding (Diluted)	210.95M	187.47M	182.78M	165.95M	138.46M	118.4M	116.89M	43.5M	37.72M
EPS (Basic)	-0.33	-0.28	-0.58	-1.48	-2.53	-2.36	-1.47	-1.77	-3.6
EPS (Diluted)	-0.33	-0.28	-0.58	-1.48	-2.53	-2.36	-1.47	-1.77	-3.6
EBITDA	-13.72M	-6.87M	-43.26M	-225.96M	-341M	-247.64M	-178.09M	-76.06M	-136.16M
EBIT	-51.23M	-45.89M	-78.54M	-262.09M	-374.59M	-286.29M	-178.16M	-76.67M	-136.46M
Depreciation & Amortization	36.75M	37.63M	35.28M	36.13M	33.59M	36.42M	2.42M	617K	296K